Profile
John Nicholas Lambert is the founder of Cryptopharma Pty Ltd. founded in 2000.
He worked as a Chief Executive Officer, Director & MD at Amplia Therapeutics Ltd. from 2020 to 2022.
He was a Principal Director-Product Development Operations at Biota Holdings Pty Ltd. from 2011 to 2013.
He worked as a Research Director-US Operations at Biota, Inc. He was a Senior Director at Medicines Development for Global Health Ltd from 2016 to 2020.
He also worked as a Senior Lecturer at the University of Melbourne and as a Vice President-Product Development & Operations at Aviragen Therapeutics, Inc. Dr. Lambert holds a doctorate degree from the University of Melbourne.
Former positions of John Nicholas Lambert
| Companies | Position | End |
|---|---|---|
| AMPLIA THERAPEUTICS LIMITED | Chief Executive Officer | 04/12/2022 |
Medicines Development for Global Health Ltd
Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Develops medicines and vaccines | Director/Board Member | 31/08/2020 |
Cryptopharma Pty Ltd.
Cryptopharma Pty Ltd. Medical SpecialtiesHealth Technology Develops novel anti-inflammatory therapeutic agents for treatment of pulmonary diseases | Founder | 03/05/2011 |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an anti-infective drug development company | Chief Operating Officer | - |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of John Nicholas Lambert
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Biota Holdings Pty Ltd.
Biota Holdings Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as an anti infective drug development company | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cryptopharma Pty Ltd.
Cryptopharma Pty Ltd. Medical SpecialtiesHealth Technology Develops novel anti-inflammatory therapeutic agents for treatment of pulmonary diseases | Health Technology |
Biota, Inc. | |
Medicines Development for Global Health Ltd
Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Develops medicines and vaccines | Health Technology |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an anti-infective drug development company | Health Technology |
Amplia Therapeutics Ltd.
Amplia Therapeutics Ltd. BiotechnologyHealth Technology Develops drug candidates for oncology and chronic fibrosis | Health Technology |
- Stock Market
- Insiders
- John Nicholas Lambert
















